Screening to prevent and delay non-communicable diseases such as cardio-vascular disease, obesity and high blood pressure is more effective and less costly than treatment.
MP Shah Hospital in Kenya has today become the first hospital in Africa to join the CaReMe Global Alliance in a landmark collaboration to improve outcomes for patients with cardiovascular, renal, and metabolic (CVRM) diseases in Kenya, including conditions like diabetes, heart failure and chronic kidney disease.
Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca, spearheading the CaReMe Global Alliance, says it is is dedicated to transforming CVRM care from an approach that targets each condition individually to one that treats all three comorbidities as one.
“This approach has already been shown to improve clinical outcomes, reduce costs and enhance resource utilisation in partner hospitals worldwide, paving the way for a more sustainable health-care model. As a member of the alliance, MP Shah Hospital is the first in Africa to embark on this innovative and integrated model of streamlined CVRM care,” read a company statement
Khomotso Mashilane, medical director for the AstraZeneca in African Cluster, said AstraZeneca is proud to support the integrated, patient-centric care approach championed by CaReMe, which has been shown to have a significant impact on the overall quality of health services and the quality of life of patients living with conditions like diabetes, heart, and kidney diseases.
“Moreover, it is a model that supports health system resilience and sustainability in Kenya by reducing costs and streamlining care, helping to pave the way for a greener, healthier tomorrow,” said Mashilane
Dr Toseef Din, CEO at MP Shah Hospital, said the hospital is thrilled to become the first in Africa to join the Global CaReMe Alliance.
“This integrated model of care for cardiovascular, renal, and metabolic diseases is proven to benefit patient outcomes and improve their overall experience, paving the way for better treatment across Kenya of these increasingly common diseases,” said Din
This collaboration aims to address this rising burden in Kenya, aiming to engage 400 patients in the iCaReMe registry in the first year. Key objectives include integrating cardiology, diabetic, and renal clinics, managing patients holistically, and evaluating outcomes based on the CaReMe Model approach.
Related Topics: